Quest Diagnostics Inc vs Logitech International SA — how do they compare? Quest Diagnostics Inc trades at $237.5 (market cap $26.21B), while Logitech International SA trades at $103.82 (market cap $14.96B). The key difference: Quest Diagnostics Inc is the larger of the two by market cap, and Logitech International SA pays the higher dividend (1.64%). Which is the better fit depends on your goals.
| DGX | LOGI | |
|---|---|---|
Market Cap | $26.21B | $14.96B |
Sector | Health | Technology |
52-Week High | $238.50 | $126.69 |
52-Week Low | $173.49 | $85.84 |
Enterprise Value | $31.97B | $13.30B |
Dividend Yield | 1.45% | 1.64% |
Trailing returns across standard periods
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →Logitech International SA is a Switzerland-based provider of personal computer and mobile accessories for navigation, video communication, and collaboration, smart home, and other applications. Its product portfolio includes mice, keyboards, charging stands, tablet cases, car mounts for mobile devices, remotes, home cameras, home switches, controllers, bluetooth speakers, surround sound, webcams, and conference cameras. It operates in a single segment namely, Peripherals. The firm generates revenue from the Americas, EMEA (Europe, Middle East, Africa), and the Asia Pacific region.
Read more on LOGI →